The value of PET/MRI in the identification of non-small cell lung cancer: stretch index diffusion imaging and metabolic parameters
Zhun Huang1, Nan Meng2, Zhixue Wang3, Fangfang Fu2, Pengyang Feng1, Ting Fang2, Yan Bai2, Wei Wei2, Yaping Wu2, Jianmin Yuan4, Yang Yang5, Hui Liu6, and Meiyun Wang*1
1Department of Radiology, Henan University People’s Hospital & Henan Provincial People’s Hospital, School of Basic Medicine, zhengzhou, China, 2Department of Radiology, Zhengzhou University People’s Hospital & Henan Provincial People’s Hospital, Academy of Medical Sciences, zhengzhou, China, 3Department of Radiology, the First Affiliated Hospital of Henan Medical University, Kai Feng, China, 4Central Research Institute, UIH Group, Shanghai, China, zhengzhou, China, 5Central Research Institute, UIH Group, Beijing, China, Bei Jing, China, 6UIH America, Inc, Houston, TX, United States, Houston, TX, United States
PET/MRI is a very promising technology. PET can reflect metabolism, and stretch index diffusion imaging can reflect molecular diffusion rate and heterogeneity.
Figure.1:
A 58-year-old male patient with lung adenocarcinoma. The white arrow points to the lesion.ADC (a), α (b), DDC (c) pseudo-color image and pet image (d).
Figure.2:Violin case diagram.α value of AC(0.64±0.19) and SCC(0.81±0.10)group(A), DDC value of AC [(2.14±0.83)×10-3 mm2
/s ]and SCC[(1.33±0.30)×10-3 mm2 /s] group(B). SUVmax value of AC (7.36±4.61) and
SCC(12.56±5.85) group(C), AC: adenocarcinoma, SCC: Squamous cell carcinoma.